Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

payer survey

- PMLiVE

Boehringer bags FDA OK for Ofev in rare lung disease ILD

First drug approved for condition

- PMLiVE

Prescription drug dependence ‘linked to deprivation’, says PHE

Public Health England publishes review on prescription rates

- PMLiVE

Breaking free

Pharma’s ability to understand and modify customer behaviour is improving – but is it doing enough?

AstraZeneca AZ

Can AZ’s Imfinzi challenge Tecentriq in small cell lung cancer?

New data shows improvement in overall survival

- PMLiVE

Lucid Group Lucky Lunches prove a spellbinding hit this summer

Lucid Group Lucky Lunches have been running throughout the summer months, giving our teams the chance to network and connect outside of the office - as well as enjoying a...

Lucid Group Communications Limited

bear in mirror

Money, money, money

Could it be, that money isn't everything afterall? Surely not.

Page & Page Health

- PMLiVE

Amgen reveals more data on KRAS drug

Unveiled an overall disease control rate of 100%

- PMLiVE

Novo follows Sanofi, Lilly with insulin price cut in US

Price cut will be effective from January 2020

- PMLiVE

Sumitomo Dainippon goes big on biotech with $3bn Roivant deal

Could acquire up to 11 Roivant spinouts

- PMLiVE

GSK eyes follow-up HPV vaccine

Announces new alliance with Chinese pharma Innovax

How to dramatically increase ROI on your eDetailing content

Take your e-detailing content and make it available to HCPs 24/7 – without losing the ‘guided’ experience that makes it so valuable.

Anthill Agency

The changing face of pharma in the precision era

Blue Latitude Health speaks to Nancy Brandt, a Senior Leader in Global Medical Information at a top 20 biopharma organisation. Here, she reveals what pharmaceutical companies need to do to...

Blue Latitude Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links